Getein Biotech, Inc (SHA:603387)
8.45
+0.05 (0.60%)
Mar 10, 2026, 2:04 PM CST
-2.20% (1Y)
| Market Cap | 4.26B |
| Revenue (ttm) | 1.04B |
| Net Income (ttm) | 208.76M |
| Shares Out | 507.15M |
| EPS (ttm) | 0.41 |
| PE Ratio | 20.47 |
| Forward PE | n/a |
| Dividend | 0.18 (2.15%) |
| Ex-Dividend Date | Sep 15, 2025 |
| Volume | 3,777,062 |
| Average Volume | 6,670,063 |
| Open | 8.44 |
| Previous Close | 8.40 |
| Day's Range | 8.38 - 8.48 |
| 52-Week Range | 7.31 - 9.23 |
| Beta | 0.30 |
| RSI | 44.09 |
| Earnings Date | Apr 30, 2026 |